Antipodes Partners’s CF Industries CF Stock Holding History

Antipodes Partners’s Portfolio CF Stock Details CF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-193	Closed	-$16K	–	71
2022 Q4	$16K	Buy	+193	New	+$19.6K	﹤0.01%	66

Other funds holding CF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Antipodes Partners's CF Position: Q1 2023 in Review

Antipodes Partners sold out of CF Industries (CF) in Q1 2023, closing a stake of 193 shares — an estimated $16K sold.

Antipodes Partners first reported a position in CF in Q4 2022 and held it in 1 quarter. The position peaked at $16K in Q4 2022. 710 funds tracked by Wall St. Rank hold CF as of Q1 2023.

Antipodes Partners reported no remaining CF Industries position as of Q1 2023 after selling out during the quarter.
Antipodes Partners sold 193 CF Industries shares in Q1 2023, an estimated $16K.
Antipodes Partners first reported a position in CF Industries in Q4 2022 and held it in 1 quarter.
Antipodes Partners's CF Industries position peaked at $16K in Q4 2022.
710 funds tracked by Wall St. Rank held CF Industries as of Q1 2023.

Based on Antipodes Partners's 13F filing for Q1 2023, filed 11 May 2023.